Cargando…
SARS-COV-2-vaccine-inactivated-Sinovac-Biotech/tozinameran: Exacerbation of pre-existing plaque psoriasis: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758378/ http://dx.doi.org/10.1007/s40278-022-08964-8 |
Ejemplares similares
-
SARS-COV-2-vaccine-inactivated-Sinovac-Biotech/tozinameran: Various toxicities: 5 case reports
Publicado: (2022) -
SARS-COV-2-vaccine-inactivated-Sinovac-Biotech/tozinameran: Subacute thyroiditis and Grave's disease: 19 case reports
Publicado: (2022) -
SARS-COV-2-vaccine-inactivated-Sinovac-Biotech: Pneumonitis and acute asthma exacerbation: case report
Publicado: (2022) -
Corticosteroids/methotrexate/sars-cov-2-vaccine-inactivated-sinovac-biotech/tozinameran: Bullous pemphigoid, exacerbation of bullous pemphigoid and SARS-COV-2 infection: 7 case reports
Publicado: (2022) -
SARS-COV-2-vaccine-inactivated-Sinovac-Biotech: Carditis: case report
Publicado: (2022)